The MTHFR C677T polymorphism contributes to increased risk of Alzheimer's Disease: Evidence based on 40 case-control studies

Neuroscience Letters

Volumn 586, Issue , 2015, Pages 36-42

  Peng, Qiliu ^a   Lao, Xianjun ^a   Huang, Xiuli ^a   Qin, Xue ^a   Li, Shan ^a   Zeng, Zhiyu ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; C677T; Meta analysis; MTHFR; Polymorphism

Indexed keywords

APOLIPOPROTEIN E4; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ALZHEIMER DISEASE; CASE CONTROL STUDY; ENZYMOLOGY; ETHNOLOGY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HUMAN; META ANALYSIS;

ALZHEIMER DISEASE; APOLIPOPROTEIN E4; CASE-CONTROL STUDIES; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, GENETIC;

EID: 84920064030     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2014.11.049     Document Type: Article

References (46)

1. Anello G., Gueant-Rodriguez R.M., Bosco P., Gueant J.L., Romano A., Namour B., Spada R., Caraci F., Pourie G., Daval J.L., Ferri R. Homocysteine and methylenetetrahydrofolate reductase polymorphism in Alzheimer's disease. NeuroReport 2004, 15:859-861.
2. Bi S., Pan S., Zhang Y., Wu J. Relationship between folate £-vitamin B12 plasma homocysteine levels and polymorphislevels ana polymorphlsms of MTHFR gene in Alzheimer's disease. Chin. J. Mod. Med. 2004, 977:15-18.
3. Bi X.H., Zhao H.L., Zhang Z.X., Zhang J.W. Association of RFC1 A80G and MTHFR C677T polymorphisms with Alzheimer's disease. Neurobiol. Aging 2009, 30:1601-1607.
4. Bosco P., Gueant-Rodriguez R.M., Anello G., Romano A., Namour B., Spada R.S., Caraci F., Tringali G., Ferri R., Gueant J.L. Association of IL-1 RN×2 allele and methionine synthase 2756 AA genotype with dementia severity of sporadic Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 2004, 75:1036-1038.
5. Brunelli T., Bagnoli S., Giusti B., Nacmias B., Pepe G., Sorbi S., Abbate R. The C677T methylenetetrahydrofolate reductase mutation is not associated with Alzheimer's disease. Neurosci. Lett. 2001, 315:103-105.
6. Chapman J., Wang N., Treves T.A., Korczyn A.D., Bornstein N.M. ACE, MTHFR, factor V Leiden, and APOE polymorphisms in patients with vascular and Alzheimer's dementia. Stroke 1998, 29:1401-1404.
7. Coppede F., Tannorella P., Pezzini I., Migheli F., Ricci G., Caldarazzo lenco E., Piaceri I., Polini A., Nacmias B., Monzani F., Sorbi S., Siciliano G., Migliore L. Folate, homocysteine, vitamin B12, and polymorphisms of genes participating in one-carbon metabolism in late-onset Alzheimer's disease patients and healthy controls. Antioxid. Redox Signaling 2012, 17:195-204.
8. da Silva V.C., Ramos F.J., Freitas E.M., de Brito-Marques P.R., Cavalcanti M.N., D'Almeida V., Cabral-Filho J.E., Muniz M.T. Alzheimer's disease in Brazilian elderly has a relation with homocysteine but not with MTHFR polymorphisms. Arq. Neuropsiquiatr. 2006, 64:941-945.
9. X. Deng, Y. Wang, Association between methylenetetrahydrofolate reductase C677T and methionine synthase A2756G gene polymorphisms, Hcy plasma levels and Alzheimer's disease, Shi Yong, Yi Xue, 28, 2012, 3545-3548.
10. Dorszewska J., Florczak J., Rozycka A., Kempisty B., Jaroszewska-Kolecka J., Chojnacka K., Trzeciak W.H., Kozubski W. Oxidative DNA damage and level of thiols as related to polymorphisms of MTHFR, MTR MTHFD1 in Alzheimer's and Parkinson's diseases. Acta Neurobiol. Exp. (Warsz.) 2007, 67:113-129.
11. Elhawary N.A., Hewedi D., Arab A., Teama S., Shaibah H., Tayeb M.T., Bogari N. The MTHFR 677T allele may influence the severity and biochemical risk factors of Alzheimer's disease in an Egyptian population. Dis. Markers 2013, 35:439-446.
12. Ferlazzo N., Gorgone G., Caccamo D., Curro M., Condello S., Pisani F., Vernieri F., Rossini P.M., Ientile R. The 894G>T (Glu298Asp) variant in the endothelial NOS gene and MTHFR polymorphisms influence homocysteine levels in patients with cognitive decline. NeuroMol. Med. 2011, 13:167-174.
13. Fernandez L.L., Scheibe R.M. Is MTHFR polymorphism a risk factor for Alzheimer's disease like APOE?. Arq. Neuropsiquiatr. 2005, 63:1-6.
14. Giedraitis V., Kilander L., Degerman-Gunnarsson M., Sundelof J., Axelsson T., Syvanen A.C., Lannfelt L., Glaser A. Genetic analysis of Alzheimer's disease in the Uppsala Longitudinal Study of Adult Men. Dement. Geriatr. Cognit. Disorder 2009, 27:59-68.
15. Goyette P., Sumner J.S., Milos R., Duncan A.M., Rosenblatt D.S., Matthews R.G., Rozen R. Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nat. Genet. 1994, 7:195-200.
16. Hua Y., Zhao H., Kong Y., Ye M. Association between the MTHFR gene and Alzheimer's disease: a meta-analysis. Int. J. Neurosci. 2011, 121:462-471.
17. Jiang K., Li F., Zhang M., Qian Y., Wang D., Zhang Y., Jiang S. A study on relathionship between the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene and Alzheimer disease. Shanghai Arch Psychiatry 2004, 16:196-208.
18. Keikhaee M.R., Hashemi S.B., Najmabadi H., Noroozian M. C677T methylentetrahydrofulate reductase and angiotensin converting enzyme gene polymorphisms in patients with Alzheimer's disease in Iranian population. Neurochem. Res. 2006, 31:1079-1083.
19. Kida T., Kamino K., Yamamoto M., Kanayama D., Tanaka T., Kudo T., Takeda M. C677T polymorphism of methylenetetrahydrofolate reductase gene affects plasma homocysteine level and is a genetic factor of late-onset Alzheimer's disease. Psychogeriatrics 2004, 4:4-10.
20. Kim J.M., Stewart R., Kim S.W., Yang S.J., Shin I.S., Shin H.Y., Yoon J.S. Methylenetetrahydrofolate reductase gene and risk of Alzheimer's disease in Koreans. Int. J. Geriatr. Psychiatry 2008, 23:454-459.
21. Kruman I.I., Kumaravel T.S., Lohani A., Pedersen W.A., Cutler R.G., Kruman Y., Haughey N., Lee J., Evans M., Mattson M.P. Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. J. Neurosci. 2002, 22:1752-1762.
22. Li K., Liu S., Yao S., Wang B., Dai D., Yao L. Interaction between interleukin-8 and methylenetetrahydrofolate reductase genes modulates Alzheimer's disease risk. Dement. Geriatr. Cognit. Disorder 2009, 27:286-291.
23. W. Liao, S. Huang, S. Chen, Y. Wang, X. Liu, The relationship of polymorphism of MTHFR and plasma homocysteine level with Alzheimer's disease, Zhong guo, You Sheng Yi, Yi Chuan, 12, 2004, 13-15.
24. Linnebank M., Linnebank A., Jeub M., Klockgether T., Wullner U., Kolsch H., Heun R., Koch H.G., Suormala T., Fowler B. Lack of genetic dispositions to hyperhomocysteinemia in Alzheimer disease. Am. J. Med. Genet. A 2004, 131:101-102.
25. Mansoori N., Tripathi M., Luthra K., Alam R., Lakshmy R., Sharma S., Arulselvi S., Parveen S., Mukhopadhyay A.K. MTHFR (677 and 1298) and IL-6-174G/C genes in pathogenesis of Alzheimer's and vascular dementia and their epistatic interaction. Neurobiol. Aging 2012, 33:1001-1008.
26. Mansouri L., Fekih-Mrissa N., Klai S., Mansour M., Gritli N., Mrissa R. Association of methylenetetrahydrofolate reductase polymorphisms with susceptibility to Alzheimer's disease. Clin. Neurol. Neurosurg. 2013, 115:1693-1696.
27. Mattson M.P., Shea T.B. Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci. 2003, 26:137-146.
28. McIlroy S.P., Dynan K.B., Lawson J.T., Patterson C.C., Passmore A.P. Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland. Stroke 2002, 33:2351-2356.
29. Nishiyama M., Kato Y., Hashimoto M., Yukawa S., Omori K. Apolipoprotein E, methylenetetrahydrofolate reductase (MTHFR) mutation and the risk of senile dementia-an epidemiological study using the polymerase chain reaction (PCR) method. J. Epidemiol. 2000, 10:163-172.
30. Pollak R.D., Pollak A., Idelson M., Bejarano-Achache I., Doron D., Blumenfeld A. The C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene and vascular dementia. J. Am. Geriatr. Soc. 2000, 48:664-668.
31. Postiglione A., Milan G., Ruocco A., Gallotta G., Guiotto G., Di Minno G. Plasma folate, vitamin B(12), and total homocysteine and homozygosity for the C677T mutation of the 5,10-methylenetetrahydrofolate reductase gene in patients with Alzheimer's dementia. A case-control study. Gerontology 2001, 47:324-329.
32. Prince J.A., Feuk L., Sawyer S.L., Gottfries J., Ricksten A., Nagga K., Bogdanovic N., Blennow K., Brookes A.J. Lack of replication of association findings in complex disease: an analysis of 15 polymorphisms in prior candidate genes for sporadic Alzheimer's disease. Eur. J. Hum. Genet. 2001, 9:437-444.
33. Religa D., Styczynska M., Peplonska B., Gabryelewicz T., Pfeffer A., Chodakowska M., Luczywek E., Wasiak B., Stepien K., Golebiowski M., Winblad B., Barcikowska M. Homocysteine, apolipoproteine E and methylenetetrahydrofolate reductase in Alzheimer's disease and mild cognitive impairment. Dement. Geriatr. Cognit. Disorder 2003, 16:64-70.
34. Seripa D., Forno G.D., Matera M.G., Gravina C., Margaglione M., Palermo M.T., Wekstein D.R., Antuono P., Davis D.G., Daniele A., Masullo C., Bizzarro A., Gennarelli M., Fazio V.M. Methylenetetrahydrofolate reductase and angiotensin converting enzyme gene polymorphisms in two genetically and diagnostically distinct cohort of Alzheimer patients. Neurobiol. Aging 2003, 24:933-939.
35. Styczynska M., Strosznajder J.B., Religa D., Chodakowska-Zebrowska M., Pfeffer A., Gabryelewicz T., Czapski G.A., Kobrys M., Karciauskas G., Barcikowska M. Association between genetic and environmental factors and the risk of Alzheimer's disease. Folia Neuropathol. 2008, 46:249-254.
36. Wakutani Y., Kowa H., Kusumi M., Yamagata K., Wada-Isoe K., Adachi Y., Takeshima T., Urakami K., Nakashima K. Genetic analysis of vascular factors in Alzheimer's disease. Ann. N. Y. Acad. Sci. 2002, 977:232-238.
37. Wang B., Jin F., Kan R., Ji S., Zhang C., Lu Z., Zheng C., Yang Z., Wang L. Association of MTHFR gene polymorphism C677T with susceptibility to late-onset Alzheimer's disease. J. Mol. Neurosci. 2005, 27:23-27.
38. Wang L., Ye L., Wu D., Liu J., Niu J. Genetic risk factors of sporadic Alzheimer's disease among Chinese in Beijing. Chin. J. Geriatr. 2004, 23:460-463.
39. Wehr H., Bednarska-Makaruk M., Lojkowska W., Graban A., Hoffman-Zacharska D., Kuczynska-Zardzewialy A., Mrugala J., Rodo M., Bochynska A., Sulek A., Ryglewicz D. Differences in risk factors for dementia with neurodegenerative traits and for vascular dementia. Dement. Geriatr. Cognit. Disorder 2006, 22:1-7.
40. Xia Y., Qin B., Man Y., Guo H., Zeng X., Wang S., Yang Z. The mutation of C677T in the methylenete trahydrofolate reductase gene is associated with Alzheimer's disease. Chin. J. Neuroimmunol. Neurol. 2002, 9:44-48.
41. Yuan Y., Ye Q., Chen Y., Zhang S., Li H., Lu R., Mei G., Li Y., Gu X., Liu Y., Wu R. Plasma homocysteine level and MTHFR gene polymorphism in old age depression and mild a Alzheimer's disease. Chin. J. Geriatr. 2007, 26:767-769.
42. Zhang J., Dai Q., Lu W., Meng F. Seruam homocysteine level and MTHFR gene polymorphism and Alzheimer's disease (AD) risk. Chin. J. Postgraduate Med. 2008, 31:40-42.
43. Zhang M.Y., Miao L., Li Y.S., Hu G.Y. Meta-analysis of the methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to Alzheimer's disease. Neurosci. Res. 2010, 68:142-150.
44. X. Zhang, Relationship of Hcy and its related enzyme gene polymorphisms with Alzheimer's disease, 2007, 1-28.
45. Zhang Y.D., Ke X.Y., Shen W., Liu Y. Relationship of homocysteine and gene polymorphisms of its related metabolic enzymes with Alzheimer's disease. Chin. Med. Sci. J. 2005, 20:247-251.
46. Zuliani G., Ble A., Zanca R., Munari M.R., Zurlo A., Vavalle C., Atti A.R., Fellin R. Genetic polymorphisms in older subjects with vascular or Alzheimer's dementia. Acta Neurol. Scand. 2001, 103:304-308.